Brief: Immunocore Announces Clinical Trial Collaboration With Sanofi To Evaluate Sanofi’ Sar444245 With Kimmtrak® In Patients With Metastatic Cutaneous Melanoma

Immunocore Holdings

03/06/2022 12:20

June 3 (Reuters) - Immunocore Holdings PLC  IMCR.O :
    * IMMUNOCORE ANNOUNCES CLINICAL TRIAL COLLABORATION WITH
SANOFI TO
EVALUATE SANOFI’S PRODUCT CANDIDATE SAR444245, NON-ALPHA IL-2,
IN COMBINATION WITH KIMMTRAK® IN PATIENTS WITH METASTATIC
CUTANEOUS MELANOMA

Source text for Eikon:  ID:nGNX172LLt 
Further company coverage:  IMCR.O 

 ((Reuters.Briefs@thomsonreuters.com;))